Skip to content
Review Open access

VENI, VIDI, VICI: The advantage of early epilepsy surgery in drug-sensitive patients.

Sep 2026 · Epilepsia · 0 citations · 48 references
Medicine

TL;DR

Baseline preservation of cognitive function and QoL, together with the stability of these measures after surgery, suggests that timely surgery may help prevent deterioration in cognitive and psychosocial functioning.

Abstract

Objective

Surgical intervention is frequently considered for drug-resistant focal structural epilepsy. However, the impact of early surgery on seizure control, cognitive performance, and quality of life (QoL) across drug-sensitive and drug-resistant patients remains incompletely characterized.

Methods

We conducted a prospective-retrospective study on 214 patients with age > 6 years with focal structural epilepsy (focal cortical dysplasia type II, hippocampal sclerosis, low-grade epilepsy-associated tumors) stratified as: drug-sensitive (DS, n = 72) and drug-resistant (DR, n = 112) patients undergoing surgery, and drug-resistant patients on pharmacological treatment (DRT, n = 30). Cognitive function (including language, verbal and visuospatial memory, attention/executive functions) and QoL (using the Quality of Life in Epilepsy Inventory [QOLIE] and 36-Item Short Form Survey [SF-36] questionnaires) were assessed at baseline and 1-year follow-up in patient subgroups. Statistical analyses included chi-square tests, t tests, analysis of variance (ANOVA), and multivariable regression models; p < .05 was considered statistically significant.

Results

The DS patients demonstrated superior rates of complete seizure freedom (86%) compared with DR patients (69%, p = .009). At baseline, DS patients exhibited significantly fewer cognitive deficits compared with DR and DRT patients (p < .05). At the 1-year follow-up, no significant changes in neuropsychological performance were observed in any group, although a mild decline in verbal and/or visuospatial memory performance was observed in DRT patients. In a subset of patients (n = 59 adults) at baseline, DR and DRT patients reported significantly worse overall subjective QoL compared with DS patients (p = .047 and p = .036, respectively). Longitudinal analysis revealed significant improvements in QoL among surgically treated patients.

Significance

Early epilepsy surgery in symptomatic focal epilepsy yields excellent seizure outcomes, particularly in DS patients. Baseline preservation of cognitive function and QoL, together with the stability of these measures after surgery, suggests that timely surgery may help prevent deterioration in cognitive and psychosocial functioning. These findings support early referral for surgical evaluation in selected patients and highlight the need for larger studies with extended follow-up, to confirm surgical outcome, long-term neuropsychological, and patient-reported benefits.

Read PDF

Similar papers

Open access Oct 2026

Pioneering Epilepsy Surgery in Cameroon: Outcomes from the First Prospective Cohort of Surgical Patients with Drug-Resistant Epilepsy.

OBJECTIVE This study aimed to assess the quality of life and cognitive well-being of patients operated on for drug resistant epilepsy (DRE) in Cameroon. METHODS We conducted a single-center, prospective single-arm cohort of 31 patients with DRE who underwent epilepsy surgery between January 2018 and March 2024. Prima...

Ghislain Guea Ngbwa, Oumarou Haman Nassourou, Evina Bekolo Nga et al. · 0 citations
Review Open access Aug 2026

Surgical Selection in Drug-Resistant Epilepsy: A Contemporary Evidence-Based Review of Patient Stratification, Presurgical Evaluation, and Surgical Outcomes

Continued advances in imaging, electrophysiology, minimally invasive techniques, and neuromodulation are transforming the management of DRE and facilitating increasingly individualized treatment strategies.

Vartika Gupta, Pankaj Gupta · 0 citations
Open access Sep 2026

Neurobehavioral outcomes following epilepsy surgery in tuberous sclerosis complex: A retrospective study.

INTRODUCTION Tuberous sclerosis complex (TSC) is a rare genetic disorder with a high prevalence of drug-resistant epilepsy. In such cases, epilepsy surgery may render 60% of suitable candidates seizure-free. Although seizure reduction may contribute to improvements in cognitive or language skills, little is known about...

Kevin Pearsson, Mikaela Selby, Ellen C. Broekhuizen et al. · 0 citations
Review Open access Sep 2026

Deep brain stimulation outcomes in pediatric drug-resistant epilepsy: A systematic review and meta-analysis.

OBJECTIVE Deep brain stimulation (DBS) is an emerging treatment option for pediatric drug-resistant epilepsy (DRE), but evidence regarding its long-term efficacy and safety remains limited. We aimed to assess the long-term efficacy and safety of DBS in children with DRE at a minimum follow-up of 12 months. METHODS A...

Asmaa Mhanna, Michael A. Ciliberto, S. Ganganna et al. · 0 citations
Review Aug 2026

Neuromodulation methods in the treatment of drug-resistant epilepsy: history, clinical efficacy and unresolved issues. A literature review

Drug-resistant epilepsy affects approximately one-third of patients and is often not amenable to resective surgery due to the bilateral nature of the epileptogenic network, multifocality, or localization of the seizure onset zone within eloquent cortical areas. In such cases, neuromodulation techniques are preferable,...

D. Sevastyanov, A. Kholyavin · 0 citations
Open access Sep 2026

Drug-resistant epilepsy: A retrospective observational study at a tertiary care hospital

Objective: To determine the prevalence and predictors of drug-resistant epilepsy among patients with epilepsy. Methodology: A retrospective observational study was conducted at the Neurology Department of Liaquat National Hospital, Karachi, for the period from November, 2024 to October, 2025. Patients with epilepsy wer...

Saba Zaidi, Umer Barry, Malaika Ali · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.